MedAdvisor : Update - Proposed issue of securities - MDR

Proposed issue of securities

Update Summary

For personal use only

Entity name

MEDADVISOR LIMITED

Announcement Type

Update to previous announcement

Date of this announcement

29/7/2022

Reason for update to a previous announcement

Amendment to Part 3D - accelerated timetable.

Amendment to Part 3E - underwriting/sub-underwriting arrangements

Refer to next page for full details of the announcement

Proposed issue of securities

1 / 11

Proposed issue of securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of +Entity

MEDADVISOR LIMITED

We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.

If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation).

1.2	Registered Number Type	Registration Number
ABN	17145327617
1.3	ASX issuer code
MDR

1.4 The announcement is

Update/amendment to previous announcement

1.4a Reason for update to a previous announcement

Amendment to Part 3D - accelerated timetable.

Amendment to Part 3E - underwriting/sub-underwriting arrangements

1.4b Date of previous announcement to this update

25/7/2022

1.5 Date of this announcement

29/7/2022

1.6 The Proposed issue is: An accelerated offer

A placement or other type of issue

1.6b The proposed accelerated offer is

Accelerated non-renounceable entitlement offer (commonly known as a JUMBO or ANREO)

Proposed issue of securities

2 / 11

Proposed issue of securities

Part 3 - Details of proposed entitlement offer issue

only
	Part 3A - Conditions
		3A.1 Do any external approvals need to be obtained or other conditions satisfied before the entitlement offer can
		proceed on an unconditional basis?
use	No
	Part 3B - Offer details
		Class or classes of +securities that will participate in the proposed issue and class or classes of +securities
personal	proposed to be issued
ASX +security code and description
		MDR : ORDINARY FULLY PAID
		Is the proposed security a 'New	Will the proposed issue of this	If the entity has quoted company
		class' (+securities in a class that is	+security include an offer of	options, do the terms entitle option
		not yet quoted or recorded by ASX)	attaching +securities?	holders to participate on exercise?
		or an 'Existing class' (additional	No	No
		securities in a class that is already
		quoted or recorded by ASX)?
		Existing class
	D tails of +securities proposed to be issued
		ASX +security code and description
		MDR : ORDINARY FULLY PAID
For	ISIN Code (if Issuer is a foreign company and +securities are non CDIs)
ISIN Code for the entitlement or right to participate in the offer (if Issuer is

foreign company and +securities are non CDIs)

Offer ratio (ratio to existing holdings at which the proposed +securities will be issued)

Has the offer ratio been determined?

Yes

The quantity of additional +securities For a given quantity of +securities

Proposed issue of securities

3 / 11

Proposed issue of securities

to be issued	held
5	21

For personal use only

What will be done with fractional	Maximum number of +securities
entitlements?	proposed to be issued (subject to
	rounding)
Fractions rounded down to the nearest	104,263,912
whole number or fractions disregarded

Offer price details for retail security holders

Has the offer price for the retail offer been determined?

Yes

In what currency will the offer be	What is the offer price per +security
made?	for the retail offer?
AUD - Australian Dollar	AUD 0.14000

Offer price details for institutional security holders

Has the offer price for the institutional offer been determined?

Yes

In what currency will the offer be	What is the offer price per +security
made?	for the institutional offer?
	AUD 0.14000
AUD - Australian Dollar

Oversubscription & Scale back details

Will individual +security holders be permitted to apply for more than their entitlement (i.e. to over-subscribe)?

Yes

Describe the limits on over-subscription

Eligible retail shareholders may apply for new MedAdvisor Limited ordinary shares (New Shares) in excess of their entitlement (Additional New Shares).

Any Additional New Shares will be limited to the extent that there are sufficient New Shares from eligible retail shareholders who do not take up their full entitlements.

Will a scale back be applied if the offer is over-subscribed?

Yes

Describe the scale back arrangements

If there are excess oversubscription applications MedAdvisor Limited reserves the right to scale back applications for Additional New Shares at its absolute discretion.

If in the event of a scale the difference between the application monies received and the number of Additional New Shares allocated to an eligible retail shareholder multiplied by the offer price will be refunded following the allotment. No interest will be paid on any application monies received and returned.

Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class?

Proposed issue of securities

4 / 11

Proposed issue of securities

Yes

Part 3D - Timetable

only	3D.1a First day of trading halt
25/7/2022
3D.1b Announcement date of accelerated offer
use	25/7/2022
3D.2 Trading resumes on an ex-entitlement basis (ex date)
	27/7/2022
	3D.5 Date offer will be made to eligible institutional +security holders
personal	25/7/2022
3D.6 Application closing date for institutional +security holders
	26/7/2022
	3D.8 Announcement of results of institutional offer
	(The announcement should be made before the resumption of trading following the trading halt)
	27/7/2022
	3D.9 +Record date
	27/7/2022
	3D.10a Settlement date of new +securities issued under institutional
	entitlement offer
	1/8/2022
	3D.10b +Issue date for institutional +security holders
For	1/8/2022
3D.10c Normal trading of new +securities issued under institutional
	entitlement offer
	2/8/2022
	3D.11 Date on which offer documents will be sent to retail +security holders
	entitled to participate in the +pro rata issue
	1/8/2022
	3D.12 Offer closing date for retail +security holders
	15/8/2022

Proposed issue of securities

5 / 11